Phase I dose-finding study of a new taxane, RPR 109881A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors. (Q53900332)
scientific article
Language:
Current Data About Phase I dose-finding study of a new taxane, RPR 109881A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors.
(P31) (Q13442814)
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

(P304) 4098-4108
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

(P407) (Q1860)

(P433) 24
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

(P478) 18
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

(P577) Friday, December 1, 2000
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

(P1433) (Q400292)
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

(P1476) "Phase I dose-finding study of a new taxane, RPR 109881A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors." (language: en)
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

(P2093) K A Gelmon
(P1545) 1
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

J Latreille
(P1545) 2
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

A Tolcher
(P1545) 3
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

L Génier
(P1545) 4
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

B Fisher
(P1545) 5
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

D Forand
(P1545) 6
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

S D'Aloisio
(P1545) 7
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

L Vernillet
(P1545) 8
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

L Daigneault
(P1545) 9
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

A Lebecq
(P1545) 10
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

M Besenval
(P1545) 11
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

E Eisenhauer
(P1545) 12
(P248)
(P698) 11118471
(P813) Tuesday, May 22, 2018
(P854) http://europepmc.org/abstract/MED/11118471

other details
description scientific article

External Links
(P356) 10.1200/JCO.2000.18.24.4098
(P698) 11118471